Abalos Therapeutics
GermanyEntry
2019
Hold
7yr
Status
Active
Who owns Abalos Therapeutics?
Abalos Therapeutics is a German Biotech company, currently owned by coparion since 2021 and 3 other investors.
Hand-verified · updated 2026-07-03
Open JSON · CC-BY
Most recent investor
Gruenderfonds RuhrGruenderfonds Ruhr I · 2017 · VC
4 ownership periods · full history below
Key facts
HQGermany
SectorBiotech
StatusActive
Key takeaways
- ·Co-held by NRW.BANK, Boehringer Ingelheim Venture Fund, Gruenderfonds Ruhr and coparion since 2019.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
Active
Co-invest · 4 holders · 2019 · present
NRW.BANKActive
2019 · present(7yr) · NRW.Venture · 2006 · VC
Gruenderfonds RuhrActive
2019 · present(7yr) · Gruenderfonds Ruhr I · 2017 · VC
coparionActive
2021 · present(5yr) · coparion · 2016 · VC
More from Gruenderfonds Ruhr I
Other portfolio companies in the same fund.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns Abalos Therapeutics?
Abalos Therapeutics is currently owned by coparion, NRW.BANK and 2 others, through Gruenderfonds Ruhr I, since 2021.
When did coparion and 3 others acquire Abalos Therapeutics?
coparion and 3 others acquired Abalos Therapeutics in 2021.
Who has owned Abalos Therapeutics over time?
Abalos Therapeutics has been through 4 private-equity ownership periods: NRW.BANK · via NRW.Venture · since 2019; Boehringer Ingelheim Venture Fund · via Boehringer Ingelheim Venture Fund · since 2019; Gruenderfonds Ruhr · via Gruenderfonds Ruhr I · since 2019; coparion · via coparion · since 2021.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue